BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26443862)

  • 1. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
    Shende VR; Singh AB; Liu J
    Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.
    Singh AB; Liu J
    J Biol Chem; 2017 Jan; 292(3):884-897. PubMed ID: 27913621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
    Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
    Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
    Cao A; Li H; Zhou Y; Wu M; Liu J
    J Biol Chem; 2010 May; 285(22):16664-74. PubMed ID: 20308079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter.
    Singh AB; Kan CF; Dong B; Liu J
    J Biol Chem; 2016 Mar; 291(10):5373-84. PubMed ID: 26728456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells.
    Sekar N; Veldhuis JD
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E128-35. PubMed ID: 14998783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter.
    Li C; Kraemer FB; Ahlborn TE; Liu J
    J Biol Chem; 1999 Mar; 274(10):6747-53. PubMed ID: 10037774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins.
    Yashiro T; Nanmoku M; Shimizu M; Inoue J; Sato R
    Atherosclerosis; 2012 Feb; 220(2):369-74. PubMed ID: 22153697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbacyclin induces carnitine palmitoyltransferase-1 in cardiomyocytes via peroxisome proliferator-activated receptor (PPAR) delta independent of the IP receptor signaling pathway.
    Kuroda T; Hirota H; Fujio Y; Sugiyama S; Masaki M; Hiramoto Y; Shioyama W; Okamoto K; Hori M; Yamauchi-Takihara K
    J Mol Cell Cardiol; 2007 Jul; 43(1):54-62. PubMed ID: 17540403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
    Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARdelta increases expression of the human apolipoprotein A-II gene in human liver cells.
    Thulin P; Glinghammar B; Skogsberg J; Lundell K; Ehrenborg E
    Int J Mol Med; 2008 Jun; 21(6):819-24. PubMed ID: 18506377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells.
    Liu J; Grove RI; Vestal RE
    Cell Growth Differ; 1994 Dec; 5(12):1333-8. PubMed ID: 7696181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters.
    Dong B; Wu M; Li H; Kraemer FB; Adeli K; Seidah NG; Park SW; Liu J
    J Lipid Res; 2010 Jun; 51(6):1486-95. PubMed ID: 20048381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function.
    Natesampillai S; Fernandez-Zapico ME; Urrutia R; Veldhuis JD
    J Biol Chem; 2006 Feb; 281(6):3040-7. PubMed ID: 16303770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein phosphatase 2A (PP2A) regulates low density lipoprotein uptake through regulating sterol response element-binding protein-2 (SREBP-2) DNA binding.
    Rice LM; Donigan M; Yang M; Liu W; Pandya D; Joseph BK; Sodi V; Gearhart TL; Yip J; Bouchard M; Nickels JT
    J Biol Chem; 2014 Jun; 289(24):17268-79. PubMed ID: 24770487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.
    Singh AB; Dong B; Kraemer FB; Xu Y; Zhang Y; Liu J
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2448-2459. PubMed ID: 30354208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase A2-modified low-density lipoprotein activates macrophage peroxisome proliferator-activated receptors.
    Namgaladze D; Morbitzer D; von Knethen A; Brüne B
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):313-20. PubMed ID: 19948841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
    Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
    Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta.
    Brunelli L; Cieslik KA; Alcorn JL; Vatta M; Baldini A
    Circ Res; 2007 Mar; 100(5):e59-71. PubMed ID: 17303761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.